Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

A look at emerging research into a potential long-lasting treatment for high cholesterol, exploring the science, findings, ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62 ...

Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American ...

High cholesterol, or hypercholesterolemia, affects nearly 1 in 3 American adults—yet it often goes undetected until a serious event like a heart attack or stroke occurs. It's one of the major ...

Eli Lilly said it received positive results from its phase 1b clinical trials for its experimental gene editing treatment for high cholesterol.

CLEVELAND — Gene editing is the revolution in medical history and a groundbreaking Cleveland Clinic trial is demonstrating how this technology could transform the way millions of Americans manage high ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point ...

Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. It’s a surprisingly young ...